Author:
Shore N D,Abrahamsson P-A,Anderson J,Crawford E D,Lange P
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference99 articles.
1. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD et al. Guidelines on prostate cancer. 2012; Available from: http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf . Accessed April 2012.
2. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™. Prostate Cancer. National Comprehensive Cancer Network: Fort Washington, PA, Version 2.2012. Available from: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf . Accessed April 2012.
3. Payne H, Mason M . Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments. Br J Cancer 2011; 105: 1628–1634.
4. Lee WR . The role of androgen deprivation therapy combined with prostate brachytherapy. Urology 2002; 60 (3 Suppl 1): 39–44.
5. Zinner NR, Bidair M, Centeno A, Tomera K . Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: results of a randomized open-label trial. Urology 2004; 64: 1177–1181.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献